Skip to content

Serotonin: all studies

Page 68 of 400: studies 671 to 680 of 3,999, newest first. Back to the serotonin overview

Research

Structure–activity relationships of serotonin 5‐HT2Aagonists

Wiley Interdisciplinary Reviews Membrane Transport and Signalling February 28, 2012 David E. Nichols 80 citations

Abstract Of the 14 known types of serotonin receptors one of the most extensively studied is the 5‐HT 2A (5‐hydroxytryptamine) receptor. In the brain, this receptor plays a key role in regulation of cortical function and cognition, appears to be the principal target for the hallucinogenic/psychedelic drugs such as lysergic acid diethylamide (LSD), and also is a target for the newest atypical...

Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism.

Neuropsychopharmacology February 2012 Lucila Kargieman, Maurizio S Riga, Francesc Artigas et al.

The non-competitive NMDA receptor (NMDA-R) antagonist phencyclidine (PCP)-used as a pharmacological model of schizophrenia-disrupts prefrontal cortex (PFC) activity. PCP markedly increased the discharge rate of pyramidal neurons and reduced slow cortical oscillations (SCO; 0.15-4 Hz) in rat PFC. Both effects were reversed by classical (haloperidol) and atypical (clozapine) antipsychotic drugs....

Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.

European Journal of Pharmacology January 15, 2012 Samanta Yubero‐lahoz, Mario A Ayestas, Bruce E. Blough et al.

(±)-3,4-Methylenedioxymethamphetamine (MDMA) is an illicit drug that evokes transporter-mediated release of serotonin (5-HT) in the brain. 5-HT transporter (SERT) proteins are also expressed in non-neural tissues (e.g., blood), and evidence suggests that MDMA targets platelet SERT to increase plasma 5-HT. Here we tested two hypotheses related to the effects of MDMA on circulating 5-HT. First,...

The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals.

PLoS One 2012 Anne Klomp, Bjørnar den Hollander, Kora de Bruin et al.

Little is known on the effects of ecstasy (MDMA, a potent 5-HT-releaser and neurotoxin) exposure on brain development in teenagers. The objective of this study was to investigate whether in humans, like previous observations made in animals, the effects of MDMA on the 5-HT system are dependent on age-of-first exposure. 5-HT transporter (SERT) densities in the frontal cortex and midbrain were...

[Anterior prefrontal cortex and serotonergic system activation during Zen meditation practice induces negative mood improvement and increased alpha band in EEG].

Rinsho shinkeigaku = Clinical neurology 2012 Hideho Arita

To gain insight into the neurophysiological mechanisms involved in Zen meditation, we evaluated the effects of abdominal (Tanden) breathing in novices. We investigated hemodynamic changes in the prefrontal cortex (PFC), an ttention-related brain region, using 24-channel near-infrared spectroscopy during a 20-munite session of Tanden breathing in 15 healthy volunteers. We found that the level of...

Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia

Seeing and Perceiving 2012 David Luke, Devin B. Terhune, Ross Friday 11 citations

The neurobiology of synaesthesia is receiving growing attention in the search for insights into consciousness, such as the binding problem. One way of decoding the neurocognitive mechanisms underlying this phenomenon is to investigate the induction of synaesthesia via neurochemical agents, as commonly occurs with psychedelic substances. How synaesthesia is affected by drugs can also help inform...

Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)

Pharmacology, Biochemistry, and Behavior December 15, 2011 Emmanuelle A. D. Schindler, Kuldip D. Dave, Elaine M. Smolock et al. 18 citations

RationaleAfter decades of social stigma, hallucinogens have reappeared in the clinical literature demonstrating unique benefits in medicine. The precise behavioral pharmacology of these compounds remains unclear, however.ObjectivesTwo commonly studied hallucinogens, (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD), were investigated both in vivo and...

Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA

Journal of Neuroinflammation December 1, 2011 Andrea Mayado, Elisa Torres, Maria D Gutierrez-Lopez et al. 8 citations

AbstractBackgroundPreconditioning is a phenomenon by which tolerance develops to injury by previous exposure to a stressor of mild severity. Previous studies have shown that single or repeated low dose MDMA can attenuate 5-HT transporter loss produced by a subsequent neurotoxic dose of the drug. We have explored the mechanism of delayed preconditioning by low dose MDMA.MethodsMale Dark Agouti...

Neonatal Citalopram Treatment Inhibits the 5-HT Depleting Effects of MDMA Exposure in Rats

ACS Chemical Neuroscience October 21, 2011 Tori L. Schaefer, Curtis E. Grace, Matthew R. Skelton et al. 5 citations

Neonatal exposure to 3,4-methylenedioxymethamphetamine (MDMA) produces long-term learning and memory deficits and increased anxiety-like behavior. The mechanism underlying these behavioral changes is unknown but we hypothesized that it involves perturbations to the serotonergic system as this is the principle mode of action of MDMA in the adult brain. During development 5-HT is a neurotrophic...

Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity.

Synapse October 2011 Melanie Mueller, Jie Yuan, Concepcion Maldonado Adrian et al.

3,4-Methylenedioxymethamphetamine (MDMA)'s O-demethylenated metabolite, 3,4-dihydroxymethamphetamine (HHMA), has been hypothesized to serve as a precursor for the formation of toxic catechol-thioether metabolites (e.g., 5-N-acetylcystein-S-yl-HHMA) that mediate MDMA neurotoxicity. To further test this hypothesis, HHMA formation was blocked with dextromethorphan (DXM), which competitively...